Skip to main content

Counter-Strike: Lavked vs ASTRAL (BO3) - CCT Europe Series 3 Group Stage

Lavked Price
56.0%
Volume
$990
Liquidity
$15.6K
Spread: 1.00%
Traders
35
Active positions

Counter-Strike: Lavked vs ASTRAL (BO3) - CCT Europe Series 3 Group Stage

Current: 56.0% 0.0%1 data points
Yes Price
Powered by TradingView Lightweight Charts

Market Analysis

**Market Overview** The prediction market "Counter-Strike: Lavked vs ASTRAL (BO3) - CCT Europe Series 3 Group Stage" is currently trading at 56.0% on Polymarket, reflecting real-time sentiment and odds from 35 active participants. As of June 2, 2026, this market has generated $990 in total trading volume, making it an emerging prediction market in the general category. **Current Odds & Price Action** The "Lavked" outcome is priced at 56.0%, while "ASTRAL" trades at 44.0%. The market has remained relatively stable over the past 24 hours, suggesting established consensus among traders about the likely outcome. **Liquidity & Trading Conditions** This market offers $15.6K in liquidity, suitable for retail-sized positions. **Market Timeline** This market is approaching its resolution date and will close soon.

Market Details

Created
Jun 2, 2026
Closes
Jun 2, 2026
Outcomes
Lavked / ASTRAL
Market ID
2416797
Last Updated
6h ago

Start Trading

Trade on the outcome of this event on Polymarket with low fees and high liquidity.

✓ Decentralized & transparent

✓ Low trading fees

✓ Instant settlement

Related Markets

Discover similar prediction markets

Knicks vs. Spurs

⏰ Expires Soon
Yes
37.0%
No
63.0%
Volume
$994.7K
Details
Details

US-Iran nuclear deal by July 31?

Yes
46.0%
No
54.0%
Volume
$99.6K
Details

Will Bitcoin reach $100,000 in June?

Yes
0.3%
No
99.8%
Volume
$99.4K
Details

Spread: Tampa Bay Rays (-1.5)

Yes
0.5%
No
99.5%
Volume
$99.1K
Details

Will the price of XRP be above $1.40 on June 2?

⏰ Expires Soon
Yes
0.3%
No
99.7%
Volume
$99.0K
Details

Ready to trade on this market?

Join thousands of traders on Polymarket and start betting on real-world events.